Jasper Therapeutics (JSPR) Current Leases (2021 - 2026)

Jasper Therapeutics has reported Current Leases for 6 years, with the latest figure at $270000.0 in Q2 2026.

• On a quarterly basis, Current Leases fell 86.18% year-over-year to $270000.0 in Q2 2026; TTM through Jun 2026 was $270000.0, a 86.18% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, up 13.41% from the prior year.
• Current Leases was $270000.0 for Q2 2026 at Jasper Therapeutics, down from $1.2 million in the prior quarter.
• The five-year high for Current Leases was $2.0 million in Q2 2025, with the low at $270000.0 in Q2 2026.
• Average Current Leases over 5 years is $1.1 million, with a median of $972000.0 recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Current Leases soared 89.89% in 2025, then tumbled 86.18% in 2026.
• Over 5 years, Current Leases stood at $865000.0 in 2022, then rose by 12.37% to $972000.0 in 2023, then climbed by 12.04% to $1.1 million in 2024, then grew by 13.41% to $1.2 million in 2025, then slumped by 78.14% to $270000.0 in 2026.
• The last three Current Leases figures came in at $270000.0 (Q2 2026), $1.2 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.